For a number of years now, Australia - and more specifically Queensland - has become the destination of choice for foreign investors looking to conduct clinical trials in the Asia-Pacific Region. Australia is commonly seen as a 'stepping-stone' to US and European markets and an excellent place for bridging trials for the Asian Market. Much of this can be attributed to Australia's geographical location, its multicultural population and strong ties with neighbouring Asian countries.

In recent years, the life sciences industry in Queensland has been fuelled by significant support and investment from both the Queensland State Government and the Australian Federal Government.

The State Government has recognised that the life sciences industry is central to building a strong and diverse economy for Queensland. Thus, as part of its Smart State and 'Towards Q2: Tomorrow's Queensland' strategies, it has invested AU$3.4 billion over the past decade in innovation, R&D and technology to drive Queensland's economy.